Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

ClinicalTrials.gov ID: NCT03240575

Public ClinicalTrials.gov record NCT03240575. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Double-dummy, Active-controlled, Multi-center, Parallel Group Study to Show the Superiority in Lung Function of 12 Weeks Once Daily Treatment With Orally Inhaled Tiotropium+Olodaterol Fixed Dose Combination Delivered by the Respimat® Inhaler vs. 12 Weeks Twice Daily Treatment With Fluticasone Propionate+Salmeterol Fixed Dose Combination Delivered by the Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [ENERGITO® 2]

Study identification

NCT ID
NCT03240575
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
302 participants

Conditions and interventions

Interventions

  • Tiotropium Drug
  • Olodaterol Drug
  • Fluticasone propionate Drug
  • Salmeterol Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2017
Primary completion
Apr 7, 2019
Completion
May 5, 2019
Last update posted
Apr 15, 2020

2017 – 2019

United States locations

U.S. sites
45
U.S. states
21
U.S. cities
43
Facility City State ZIP Site status
Jasper Summit Research, LLC Jasper Alabama 35501
Clinical Trial Connection Flagstaff Arizona 86001
California Research Medical Group, Inc. Fullerton California 92835
Allergy and Asthma Specialists Medical Group Huntington Beach California 92647
California Medical Research Associates Inc. Northridge California 91324
IMMUNOe Research Centers Centennial Colorado 80112
Clinical Research of West Florida, Inc. Clearwater Florida 33765
Bioclinica Research Orlando Florida 32806
IMIC, Inc Palmetto Bay Florida 33157
Clinical Research of West Florida, Inc. Tampa Florida 33603
Duluth Biomedical Research Duluth Georgia 30096
DC Pulmonary Medicine Marietta Georgia 30060
New Orleans Center for Clinical Research New Orleans Louisiana 70119
Johns Hopkins Hospital Baltimore Maryland 21224
Pulmonary Rsrch Inst of SE MI Farmington Hills Michigan 48336
Minnesota Lung Center and Sleep Institute Edina Minnesota 55435
Clinical Research Institute Inc Minneapolis Minnesota 55402
Minnesota Lung Center Woodbury Minnesota 55125
The Clinical Research Center, LLC St Louis Missouri 63141
Northwell Health New Hyde Park New York 11040
Gastonia Pharmaceutical Research, LLC Gastonia North Carolina 28054
Hendersonville Pharmaceutical Research Hendersonville North Carolina 28739
North Carolina Clinical Research Raleigh North Carolina 27607
Southeastern Research Center Winston-Salem North Carolina 27103
Bernstein Clinical Rsrch Ctr Cincinnati Ohio 45231
Aventiv Research Inc. Columbus Ohio 43213
Aventiv Research Inc. Dublin Ohio 43016
OK Clinical Research, LLC Edmond Oklahoma 73034
IPS Research Company Oklahoma City Oklahoma 73103
Arcuri Clinical Research, LLC Philadelphia Pennsylvania 19142
Lowcountry Lung and Critical Care Charleston South Carolina 29406
VitaLink Research - Easley Easley South Carolina 29640
VitaLink Research -Gaffney Gaffney South Carolina 29340
VitaLink Research Greenville South Carolina 29615
Vita Link Research- Rock Hill Rock Hill South Carolina 29732
South Carolina Pharma Rsrch Spartanburg South Carolina 29303
Spartanburg Medical Research Spartanburg South Carolina 29303
Centex Studies, Inc. Houston Texas 77058
Advanced Clinical Research Associates Plano Texas 75093
Sherman Clinical Research Sherman Texas 75092
DM Clinical Research Tomball Texas 77375
Pulmonary Associates of Richmond, Inc. Richmond Virginia 23225
Pulmonary Associates of Richmond, Inc. Richmond Virginia 23229
MultiCare Institute for Research and Innovation Tacoma Washington 98405
Morgantown Pulmonary ClinRsrch Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03240575, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2020 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03240575 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →